Cardiovascular adverse conditions are caused by coronavirus disease 2019 (COVID-19)
infections and reported as side-effects of the COVID-19 vaccines. Enriching current vaccine …

In an updated self-controlled case series analysis of 42,200,614 people aged 13 years or
more, we evaluate the association between COVID-19 vaccination and myocarditis, stratified …

Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have
been approved for emergency use before completing all 3 phases of the clinical trials …

Several studies have reported associations between COVID-19 vaccination and risk of
cardiac diseases, especially in young people; the impact on mortality, however, remains …

Background Thirteen COVID-19 vaccines are granted emergency approval. It is crucial to
monitor their adverse events post vaccination. The present study focuses on cardiovascular …

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination —
PCORnet, United States, January 2021–January 2022 | MMWR Skip directly to site content Skip …

Background: Two coronavirus disease 2019 (COVID-19) vaccines have received
emergency use authorizations in the US However, the safety of these vaccines in the real …

Background: Myocarditis is more common after severe acute respiratory syndrome
coronavirus 2 infection than after COVID-19 vaccination, but the risks in younger people and …

Although myocarditis and pericarditis were not observed as adverse events in coronavirus
disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected …

Importance Reports of myocarditis after SARS-CoV-2 messenger RNA (mRNA) vaccination
have emerged. Objective To evaluate the risks of myocarditis and pericarditis following …